STEMVAC in Patients With Early Stage Triple Negative Breast Cancer
Clinical trial NCT05455658 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05455658
- Sponsor
- University of Washington
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-17
- Primary completion
- 2026-06-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.